Pear Therapeutics (PEAR)
US Market

Pear Therapeutics (PEAR) Financial Statements


Pear Therapeutics Financial Overview

Pear Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Pear Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 2.56M$ 4.08M$ 3.30M$ 2.75M$ 1.32M
Gross Profit$ 820.00K$ 1.53M$ 896.00K$ 1.27M$ -328.00K
EBIT$ -29.16M$ -26.63M$ -32.82M$ -34.74M$ -34.23M
EBITDA$ -27.63M$ -25.16M$ -31.42M$ -33.45M$ -33.49M
Net Income Common Stockholders$ -26.37M$ -30.72M$ 5.46M$ -23.86M$ 18.75M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 59.27M$ 83.62M$ 107.11M$ 137.40M$ 174.57M
Total Assets$ 95.13M$ 119.73M$ 142.52M$ 172.09M$ 197.16M
Total Debt$ 37.61M$ 38.06M$ 38.39M$ 38.63M$ 26.99M
Net Debt$ -21.66M$ -45.56M$ -68.72M$ -98.78M$ -147.58M
Total Liabilities$ 64.54M$ 67.49M$ 63.48M$ 102.58M$ 106.73M
Stockholders Equity$ 30.59M$ 52.25M$ 79.04M$ 69.51M$ 90.43M
Cash Flow-
Free Cash Flow$ -25.35M$ -23.85M$ -30.96M$ -37.21M$ -42.10M
Operating Cash Flow$ -24.28M$ -23.27M$ -29.64M$ -36.71M$ -39.84M
Investing Cash Flow$ 11.93M$ 22.42M$ -307.00K$ -43.50M$ -1.75M
Financing Cash Flow$ 961.00K$ 358.00K$ 761.00K$ 75.00K$ 147.98M
Currency in USD

Pear Therapeutics Earnings and Revenue History

Pear Therapeutics Debt to Assets

Pear Therapeutics Cash Flow

Pear Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis